Peak6 Investments LLC Bluebird Bio, Inc. Put Options Transaction History

Peak6 Investments LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $393,400 - $735,000	-35,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $577,332 - $1.18 Million	34,800 Added 17400.0%	35,000 $1.06 Million
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $104,500 - $144,096	-3,800 Reduced 95.0%	200 $9,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $778,344 - $988,750	-22,600 Reduced 84.96%	4,000 $139,000
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $1.11 Million - $1.88 Million	-41,000 Reduced 60.65%	26,600 $1.62 Million
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $408,096 - $990,600	-15,600 Reduced 18.75%	67,600 $3.11 Million
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $3.16 Million - $4.15 Million	67,300 Added 423.27%	83,200 $7.3 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $113,760 - $157,815	1,500 Added 10.42%	15,900 $2.02 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $148,212 - $239,453	2,300 Added 19.01%	14,400 $2.27 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $1.08 Million - $1.42 Million	12,100 New	12,100 $1.77 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.